In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones

In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells Anti-Helicobacter pyloriAgents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles Anti- Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles Synthesis and in vitro anti-Helicobacter pylori activity of 2-[(chlorobenzyl)thio]-5-(5-nitro-2-furyl)-1,3,4-thiadiazoles Anti-Helicobacter pyloriAgents. 1. 2-(Alkylguanidino)-4-furylthiazoles and Related Compounds Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds Identification of 3′,4′,5′-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells Structure−Activity Relationship of 2-[[(2-Pyridyl)methyl]thio]-1H- benzimidazoles as AntiHelicobacter pyloriAgents in Vitro and Evaluation of their in Vivo Efficacy 3-(Arylacetylamino)-N-methylbenzamides:  A Novel Class of Selective Anti-Helicobacter pylori Agents